Instrument Inactif

Communiqués Neovasc Inc. Nasdaq

Actions

NVCN

CA64065J4037

Equipement et technologie médicale avancés

Communiqués

12/04/23	Neovasc : Notice of Change in Corporate Structure - Form 6-K	PU
03/04/23	Neovasc Announces Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Corporate Update	AQ
31/03/23	Neovasc: Q4 Earnings Snapshot	AQ
31/03/23	Neovasc Announces Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Corporate Update	GL
06/03/23	Neovasc : Shareholders Approve Acquisition by Shockwave Medical	PU
01/02/23	Neovasc Announces German Reimbursement Renewal	AQ
27/01/23	Neovasc : Notice of the Meeting and Record Date - Form 6-K	PU
17/01/23	IIROC Trade Resumption - NVCN	AQ
17/01/23	IIROC Trading Halt - NVCN	AQ
17/01/23	Shockwave Medical Announces Agreement to Acquire Neovasc	AQ
17/01/23	Shockwave Medical to Acquire Neovasc	AQ
28/11/22	Neovasc Announces Progress on COSIRA-II Clinical Trial	AQ
18/11/22	Neovasc Comments on European Heart Journal Publication	AQ
11/11/22	Neovasc: Q3 Earnings Snapshot	AQ
10/11/22	Neovasc Announces Third Quarter Financial Results and Provides Corporate Update	AQ
08/11/22	Neovasc Reducer Obtains U.S. Outpatient Reimbursement	AQ
27/10/22	Neovasc to Report Third Quarter Financial Results on November 10, 2022	AQ
20/09/22	Neovasc : New Data Presented on the Neovasc Reducer™ in Patients With Microvascular Disease - Form 6-K	PU
20/09/22	Neovasc Provides Corporate Update Following Clinical Data Release	AQ
16/09/22	Neovasc to Participate in LSI Europe 2022 Emerging MedTech Summit	AQ
15/09/22	Neovasc Comments on New ICD-10-CM Diagnosis Codes for Refractory Angina	AQ
08/09/22	Neovasc Announces Key Events at TCT 2022	AQ
30/08/22	Neovasc to Participate in H.C. Wainwright 24th Annual Global Investment Conference	AQ
11/08/22	Neovasc: Q2 Earnings Snapshot	AQ
11/08/22	Neovasc : Announces Second Quarter Financial Results and Provides Corporate Update - Form 6-K	PU